Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
64.45(c) 65.48(c) 63.04(c) 64.61(c) 65.01 Last
894 993 1 782 233 957 348 782 111 754 792 Volume
+0.91% +1.60% -3.73% +2.49% +0.62% Change
More quotes
Financials ($)
Sales 2016 569 M
EBIT 2016 -57,1 M
Net income 2016 -64,3 M
Debt 2016 4,66 M
Yield 2016 -
Sales 2017 767 M
EBIT 2017 1,24 M
Net income 2017 -1,83 M
Debt 2017 8,95 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 9,60x
EV / Sales2017 7,13x
Capitalization 5 461 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
12/08 DEXCOM INC : Change in Directors or Principal Officers (form 8-K)
12/08 DEXCOM : Researchers Submit Patent Application, "Needle for Transcutaneous Analy..
12/08 DEXCOM : Patent Application Titled "Needle for Transcutaneous Analyte Sensor Del..
11/22 DEXCOM : DiabetesSisters Awarded Grant from Dexcom One Step Ahead Foundation
11/22 DEXCOM ONE STEP AHEAD FOUNDATION : A Dexcom Employees Foundation Awards First Gr..
11/16 DEXCOM : Technical Reports on Healthcare Equities -- Organovo, Quest Diagnostics..
11/15 DEXCOM : Announces Upcoming Conference Presentation
11/15 DEXCOM : Diabetes management leader Dexcom expands presence in EMEA markets with..
11/14 DEXCOM : With Health Canada approval, Dexcom G5® Mobile CGM System is the First ..
11/12 DEXCOM, INC. (NASDAQ : DXCM) to Ring The Nasdaq Stock Market Opening Bell
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
12/08 MEDTRONIC : China says fines Medtronic local unit 118.5 million yuan for price f..
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
12/01 Caution On Acacia - Cramer's Lightning Round (11/30/16)
11/29 INSULET INVESTORS BEING KEPT IN THE : Significant Downside Remains
11/20 WEIGHING THE WEEK AHEAD : Digesting The Trump Stimulus Plan
11/18 STOCK EXCHANGE : How To Spot A Great Chart
11/07 Insulet Continues Pushing Forward In Diabetes Market
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 86,5 $
Spread / Average Target 34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terry H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Jess Roper Chief Financial Officer & Senior Vice President
Jorge A. Valdes Chief Technology Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.-21.11%5 461
MEDTRONIC PLC-6.31%98 956
BAXTER INTERNATIONAL I..15.54%23 976
ZIMMER BIOMET HOLDINGS..1.81%20 921
C R BARD INC11.48%15 706
HOYA CORPORATION-8.40%15 156
More Results